Premium
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Bristol-Myers Squibb Company (NYSE: BMY) (“Bristol-Myers Squibb”) announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvement Act of 1976, as...
Levi & Korsinsky is investigating the Board of Directors of Amylin Pharmaceuticals, Inc. (“Amylin” or the “Company”) (Nasdaq: AMLN) for possible breaches of fiduciary duty and...
Block & Leviton LLP Investigates Amylin Pharmaceuticals, Inc. for Possible Breaches of Fiduciary Duties in Connection with Its Proposed Merger with Bristol-Myers Squibb Company PR...
Bristol-Myers Squibb Company (NYSE: BMY) is commencing today, through its wholly owned subsidiary B&R Acquisition Company, a cash tender offer to purchase all outstanding...
Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Amylin Pharmaceuticals, Inc. PR Newswire DALLAS, July 9, 2012 DALLAS, July 9, 2012 /PRNewswire/...
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Amylin Pharmaceuticals, Inc (“Amylin” or the “Company”...
Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc. PR Newswire BALA CYNWYD, Pa., July 3, 2012 BALA CYNWYD, Pa., July 3, 2012 /PRNewswire/ -- Law office of...
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/amln) is investigating potential claims against the board of directors of Amylin Pharmaceuticals, Inc. (“Amylin” or the “Company”...
Levi & Korsinsky is investigating the Board of Directors of Amylin Pharmaceuticals, Inc. (“Amylin” or the “Company”) (Nasdaq: AMLN) for possible breaches of fiduciary duty and...
Harwood Feffer LLP Announces Investigation of Amylin Pharmaceuticals, Inc. PR Newswire NEW YORK, July 2, 2012 NEW YORK, July 2, 2012 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
